Inventor · disambiguated record
Francisco Veas
Also filed as: VEAS FRANCISCO
4 granted patents·7 pending applications·7 citations·filing 1997–2018
61Inventor score
Files withVEAS FRANCISCO3INST RECH DEVELOPPEMENT IRD2COMMISSARIAT ENERGIE ATOMIQUE1IMMUNOCLIN LTD1INST RECH POUR LE DEVELOPEMENT1
Top patents by PatentIndex Score
11 records- 0150US11419841B2Uses of lipophenolic compoundsUNIV MONTPELLIER·Filed 2018·Granted Aug 23, 2022·0 cites·3 claims
- 0248US2004076640A1Vaccine compositions against infectious pathologies for mammalsINST RECH POUR LE DEVELOPEMENT·Filed 2003·Application pending·0 cites
- 0347US2010098723A1Vaccine compositions against infectious pathologies for mammalsIRD·Filed 2009·Application pending·0 cites
- 0447US2010303858A1Chimeric HIV-1 Glycoproteins and Their Biological ApplicationsVEAS FRANCISCO·Filed 2006·Application pending·0 cites
- 0541US2002103344A1Glycoprotein mutants of retrovirus envelopes and their biological applicationsFiled 2001·Application pending·0 cites
- 0638US7374875B2Peptides having affinity for the gp120 viral protein and use thereofCOMMISSARIAT ENERGIE ATOMIQUE·Filed 2002·Granted May 20, 2008·0 cites·17 claims
- 0738US2009062375A1Methods and compositions for the treatment of viral diseasesVEAS FRANCISCO·Filed 2006·Application pending·0 cites
- 0837US2007009926A1Biomarkers of resistance to infections in humans and biological applications thereofVEAS FRANCISCO·Filed 2006·Application pending·0 cites
- 0937US2017319652A1Prevention and treatment of infectionsIMMUNOCLIN LTD·Filed 2016·Application pending·0 cites
- 1032US6465191B1Process for separating and/or detecting and/or quantifying (an) infectious compound(s) and support for implementing the processINST RECH DEVELOPPEMENT IRD·Filed 1997·Granted Oct 15, 2002·7 cites·54 claims
- 1128US7078038B1Gp120 mutants and biological applicationsINST RECH DEVELOPPEMENT IRD·Filed 1999·Granted Jul 18, 2006·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Francisco Veas files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →